SignalMacro
ExxonMobil (XOM): Can Its Chemical Recovery Survive a Smaller Cost Advantage?
ExxonMobil's chemical recovery questioned as smaller cost advantage threatens margins.
Context
What happened: ExxonMobil (XOM) raised second-quarter chemical earnings to $1.13 billion from $110 million in the first quarter, even as chemical sales volumes fell to 4.47 million tonnes from 5.36 million.
Key numbers: Q2 chemical earnings $1.13B vs $110M in Q1. Volumes 4.47M tonnes vs 5.36M.
Why it matters: The company attributed the gain to margins, including stronger North American ethane economics, while industry chemical margins stayed below its 2010 to 2019 benchmark. The content says the 15x forward valuation looks demanding if feedstock economics weaken.
Market: +2.0% today ($222.04), +45.2% YTD, 1.1x vol — as of 23:45 UTC
What changed
ExxonMobil (XOM) raised second-quarter chemical earnings to $1.13 billion from $110 million in the first quarter, even as chemical sales volumes fell to 4.47 million tonnes from 5.36 million.
Why it matters
The company attributed the gain to margins, including stronger North American ethane economics, while industry chemical margins stayed below its 2010 to 2019 benchmark. The content says the 15x forward valuation looks demanding if feedstock economics weaken.
Market: +2.0% today ($222.04), +45.2% YTD, 1.1x vol — as of 23:45 UTC